Immunovant
IMVT
IMVT
142 hedge funds and large institutions have $904M invested in Immunovant in 2023 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 57 increasing their positions, 42 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.98% more ownership
Funds ownership: 43.75% → 44.73% (+0.98%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
8% less capital invested
Capital invested by funds: $980M → $904M (-$76.5M)
Holders
142
Holding in Top 10
5
Calls
$8.97M
Puts
$1.9M
Top Buyers
| 1 | +$25.7M | |
| 2 | +$17.7M | |
| 3 | +$16.2M | |
| 4 |
Millennium Management
New York
|
+$15.5M |
| 5 |
State Street
Boston,
Massachusetts
|
+$13.3M |
Top Sellers
| 1 | -$35.7M | |
| 2 | -$35.3M | |
| 3 | -$10.5M | |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
-$10.1M |
| 5 |
Walleye Capital
New York
|
-$9.48M |